Utilization of the Shensheng-Piwen changed medicinal powder extracts combines metal-organic frameworks as an antibacterial agent.

Front Cell Infect Microbiol

State Key Laboratory of Medicinal Chemical Biology, Nankai University, Haihe Laboratory of Synthetic Biology, Tianjin, China.

Published: June 2024

AI Article Synopsis

  • Widespread opportunistic pathogens are a major global health threat, particularly in hospitals, due to rising antibiotic resistance, making the search for new treatments essential.
  • The study evaluates the antibacterial efficacy of Shensheng-Piwen changed medicinal powder (SPC) through various methods, including assessing its ability to inhibit biofilms, highlighting its multi-target properties.
  • Results indicate that SPC extracts are effective against certain pathogens, showing significant antibacterial activity and biofilm inhibition, while also revealing potential synergistic effects with Metal-Organic Frameworks (MOFs).

Article Abstract

Introduction: Widespread opportunistic pathogens pose a serious threat to global health, particularly in susceptible hospital populations. The escalating crisis of antibiotic resistance highlights the urgent need for novel antibacterial agents and alternative treatment approaches. Traditional Chinese Medicine (TCM) and its compounds have deep roots in the treatment of infectious diseases. It has a variety of active ingredients and multi-target properties, opening up new avenues for the discovery and development of antimicrobial drugs.

Methods: This study focuses on assessing the efficacy of the Shensheng-Piwen changed medicinal powder (SPC) extracts against opportunistic pathogen infections by broth microdilution and agar disc diffusion methods. Additionally, biofilm inhibition and eradication assays were performed to evaluate the antibiofilm effects of SPC extracts.

Results: Metabolite profiles were analyzed by LC-MS. Furthermore, the potential synergistic effect between SPC and Metal-Organic Framework (MOF) was investigated by bacterial growth curve analysis. The results indicated that the SPC extracts exhibited antibacterial activity against , with a minimum inhibitory concentration (MIC) of 7.8 mg/mL (crude drug concentration). Notably, at 1/2 MIC, the SPC extracts significantly inhibited biofilm formation, with over 80% inhibition, which was critical in tackling chronic and hospital-acquired infections. Metabolomic analysis of revealed that SPC extracts induced a notable reduction in the levels of various metabolites, including L-proline, L-asparagine. This suggested that the SPC extracts could interfere with the metabolism of . Meanwhile, the growth curve experiment proved that SPC extracts and MOFs had a synergistic antibacterial effect.

Discussion: In conclusion, the present study highlights the potential of SPC extracts as a novel antibacterial agent against infections, with promising biofilm inhibition properties. The observed synergistic effect between SPC extracts and MOFs further supports the exploration of this combination as an alternative treatment approach.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11193333PMC
http://dx.doi.org/10.3389/fcimb.2024.1376312DOI Listing

Publication Analysis

Top Keywords

spc extracts
32
spc
10
extracts
9
shensheng-piwen changed
8
changed medicinal
8
medicinal powder
8
antibacterial agent
8
novel antibacterial
8
alternative treatment
8
biofilm inhibition
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!